Safety and efficacy of caplacizumab retreatment in a real-life monocentric cohort of patients with immune-mediated thrombotic thrombocytopenic purpura

Caocci, G.
Co-prime
;Mulas, O.
Co-prime
;Bandinu, N.;La Nasa, G.
Last
2023-01-01
2023
Inglese
THROMBOSIS RESEARCH
WOS:001036997100001
2-s2.0-85162111898
37348319
Esperti anonimi
scientifica
Caplacizumab; TTP retreatment; Thrombotic thrombocytopenic purpura
no
Caocci, G.; Mulas, O.; Mantovani, D.; Bandinu, N.; La Nasa, G.
1.1 Articolo in rivista
info:eu-repo/semantics/article
1 Contributo su Rivista::1.1 Articolo in rivista
262
5
open
Files in This Item:
File Size Format  
pagination_TR_8776.pdf

open access

Type: versione post-print
Size 419.4 kB
Format Adobe PDF
View/Open
419.4 kB Adobe PDF View/Open

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Questionnaire and social

Share on:
Impostazioni cookie